Insider Trading History of Eisenstadt Richard I

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Eisenstadt Richard I since 2016. This trader's CIK number is 1515806. At the time of last reporting, Eisenstadt Richard I was the Chief Financial Officer of Altimmune, Inc.. (stock ticker symbol ALT). Also see all insider trading activities at Altimmune, Inc..

Note that in the past Eisenstadt Richard I also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Altimmune, Inc. (ALT) by Eisenstadt Richard I

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 ALT 0 $0 0 $0 21,775 $0
2023 ALT 10,000 $43,140 0 $0 25,000 $0

Yearly summary of insider trading at Neos Therapeutics, Inc. (NEOS) by Eisenstadt Richard I

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 NEOS 5,000 $10,820 0 $0 0 $0
2016 NEOS 3,710 $25,283 0 $0 0 $0


Insider trading activities at 2 companies by Eisenstadt Richard I:

1. Altimmune, Inc. (ALT)

2. Neos Therapeutics, Inc. (NEOS)

Table 1. Insider trading of Altimmune, Inc. (ALT) by Eisenstadt Richard I

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-01-30 ALT Option Ex 9,275 .00 0
2023-12-29 ALT Option Ex 12,500 .00 0
2023-03-24 ALT Buy 10,000 4.31 43,140
2022-12-31 ALT Option Ex 12,500 .00 0
2022-12-31 ALT Option Ex 12,500 .00 0

Table 2. Insider trading of Neos Therapeutics, Inc. (NEOS) by Eisenstadt Richard I

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-12-12 NEOS Buy 5,000 2.16 10,820
2016-08-25 NEOS Buy 3,710 6.82 25,283

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Eisenstadt Richard I (Chief Financial Officer of Altimmune, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.